4-year results from checkmate 238: adjuvant nivo vs ipi in resected stage iii/iv melanoma
Published 4 years ago • 222 plays • Length 5:44Download video MP4
Download video MP3
Similar videos
-
2:03
7-y results from checkmate 238: adjuvant nivo vs ipi in resected stage iii/iv melanoma
-
2:56
encouraging phase 3 checkmate 238 data: adjuvant nivolumab in resected stage iii/iv melanoma
-
5:30
jeffrey s weber, asco 2018 – resected stage iii melanoma and the checkmate 238 trial
-
7:04
checkmate 238: adjuvant checkpoint therapy after melanoma resection
-
1:59
checkmate 238: nivolumab versus ipilimumab in stage iii melanoma
-
0:58
impact of checkmate-238 results for patients with melanoma
-
7:39
adjuvant nivolumab versus ipilimumab for resected stage iii/iv melanoma
-
1:17
dr. weber on checkmate-238 compared to other trials in melanoma
-
1:42
dr. weber on biomarker data from checkmate-238 for melanoma
-
4:02
prado: personalized response-driven surgery and adjuvant therapy in stage iii melanoma
-
3:37
adjuvant therapy for resected stage iii melanoma
-
1:06
melanoma news from esmo 19
-
3:02
checkmate 238 results presented at esmo 2017
-
0:56
dr. weber on checkmate-238 for melanoma
-
7:55
when is a clinical trial the right option for me?
-
0:30
get a baseline eye disease screening at 40, presented by dr. robert melendez
-
2:52
education4cures - needle biopsy video by tiana visconti (cures 2020)
-
3:37
results of the cog aall0434 trial for t-cell malignancies
-
2:04
preliminary results from the blin01 trial